Jazz Pharmaceuticals to buy Chimerix for $935 million-February 2024-www.financetom.com

Jazz Pharmaceuticals to buy Chimerix for $935 million

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

Jazz Pharmaceuticals to buy Chimerix for $935 million

Mar 5, 2025 4:22 AM

March 5 (Reuters) - Jazz Pharmaceuticals ( JAZZ ) will

acquire biotech firm Chimerix ( CMRX ) for about $935 million to

gain access to its experimental drug to treat a rare brain

tumor, the companies said on Wednesday.

Previous page： Many Wall Street executives are worried about Trump but wary of Harris Next page： Many Wall Street executives are worried about Trump but wary of Harris

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Many Wall Street executives are worried about Trump but wary of Harris

Sep 26, 2024

WASHINGTON/NEW YORK, Sept 27 (Reuters) - Many Wall Street executives have reservations about backing either candidate in the U.S. presidential election, worried that former President Donald Trump's policies will hurt the economy but wary Vice President Kamala Harris will lean too far left. While multiple Wall Street heavy-hitters including Bill Ackman, John Paulson and George Soros have backed a candidate,...

Many Wall Street executives are worried about Trump but wary of Harris

Sep 26, 2024

WASHINGTON/NEW YORK (Reuters) - Many Wall Street executives have reservations about backing either candidate in the U.S. presidential election, worried that former President Donald Trump's policies will hurt the economy but wary Vice President Kamala Harris will lean too far left. While multiple Wall Street heavy-hitters including Bill Ackman, John Paulson and George Soros have backed a candidate, many other...